The Serum Lipids Levels may be Underestimated in Patients on Hemodialysis

Abstract

Objective Although lipid disorders are a well-known risk factor for cardiovascular disease (CVD) in the general population, the optimal management with lipid-lowering therapy to reduce CVD risks and mortality in hemodialysis (HD) patients remains controversial. In the clinical setting, dyslipidemia can be diagnosed based on the detection of elevated lipid concentrations at the beginning of HD. This study investigated changes in the levels of serum lipids during a single HD session. Methods The serum total cholesterol, triglyceride and high-density lipoprotein (HDL) cholesterol levels were measured in 31 HD patients at zero, two and four hours after the beginning of a single HD session. The data were analyzed using the Wilcoxon signed-rank test, a linear mixed model and Spearman's rank correlation analysis. Results The serum total cholesterol, HDL cholesterol and non-HDL cholesterol levels increased significantly during the HD session. Even after the lipid parameters were corrected for changes in the total protein level, the total cholesterol and HDL cholesterol levels increased, whereas the non-HDL cholesterol levels did not change significantly. The percentage change in the serum levels of these lipid fractions correlated strongly with the percentage change in the ultrafiltration volume per body weight. In contrast, the serum triglyceride levels were decreased significantly at two hours compared with the levels noted at the beginning of HD and gradually increased at four hours. Conclusion The serum lipid levels are influenced significantly by HD treatment and ultrafiltration. Evaluating the degree of dyslipidemia at the beginning of a HD session may therefore underestimate the levels of serum lipids in HD patients with a large amount of weight gain, thus resulting in the use of insufficient lipidlowering therapy.

Paratireoidectomia na doença renal crônica: efeitos no ganho de peso e na melhora da qualidade de vida

“…The evaluation of lipids in the pre-dialysis serum may underestimate the true lipemic levels, since before the hemodialysis (HD) sessions the individuals have greater weight (due to a greater amount of free water), impairing results and hindering therapeutic management 24 . In this study, we did not identify prePTx elevated lipids and justified the increase in LDLcholesterol after surgery by other factors, other than nutritional or metabolic, such as oxidative stress, inflammation and possible endothelial dysfunction, as described by Nitta 25 .…”

Low body cell mass index in hemodialysis patients: Association with clinical parameters and survival

“…However, genetic, ethnic, and racial factors, as well as the HD treatment and the ultrafiltration rate, can affect serum lipids and therefore patients' outcomes. 19,20 Predialysis serum creatinine concentration has been suggested as an indirect measure of muscle mass in HD patients and the International Society of Renal Nutrition and Metabolism (ISRNM) includes this parameter in the diagnostic criteria for PEW. In our study, we observed lower serum creatinine and CI in the group of patients with BCMI <6.4 kg/m 2 .…”

Nutritional parameters as mortality predictors in haemodialysis: Differences between genders

“…However, there are different factors that can affect serum lipids and therefore patient outcomes. The factors that have been described are genetic, ethnic and racial factors as well as the HD treatment per se and the ultrafiltration rate (Moradi et al ; Ueno et al ).…”